SUBSCRIBE
SUBSCRIBE

Indiana

Illustration depicting a heart, a kidney, and GLP-1 agonist injection pens
GLP-1
Beyond Weight Loss: Novo and Lilly Look to Expand Their GLP-1 Pipelines
While type 2 diabetes and obesity are the primary conditions currently treated with blockbuster GLP-1 drugs, Novo Nordisk and Eli Lilly aim to enter additional markets.

July 22, 2024
 · 
4 min read
 · 
Grant Playter
Lilly and injector pens
Weight loss
Will Eli Lilly Overtake Novo Nordisk in Weight-Loss Drug Race?  
Some analysts say so, and a recent study suggested Lilly’s tirzepatide beat Novo’s semaglutide at inducing weight loss, but there are other factors in the market race. 
July 16, 2024
 · 
4 min read
 · 
Tyler Patchen
Load More
PRESS RELEASES
Press Releases
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025
February 26, 2025
 · 
1 min read
Press Releases
Zimmer Biomet Launches You’ll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger
February 26, 2025
 · 
4 min read
Press Releases
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
February 26, 2025
 · 
9 min read
Press Releases
Zimmer Biomet Announces Upcoming Changes to Company’s Board of Directors
February 26, 2025
 · 
4 min read
Press Releases
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
February 26, 2025
 · 
7 min read
Press Releases
Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients
February 25, 2025
 · 
13 min read
Press Releases
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
February 21, 2025
 · 
10 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
 · 
4 min read
Press Releases
MBX Biosciences to Participate in March 2025 Investor Conferences
February 19, 2025
 · 
1 min read
Press Releases
Syra Health Announces Positive Preliminary Results from Syrenity Study Led by Indiana University
February 19, 2025
 · 
5 min read
Press Releases
Lilly to participate in TD Cowen’s 45th Annual Health Care Conference
February 19, 2025
 · 
2 min read
Press Releases
Roche Elecsys sFlt-1/PlGF ratio for preeclampsia receives FDA 510(k) clearance, offering a fast and reliable way to predict the risk of developing severe preeclampsia
February 14, 2025
 · 
8 min read
Press Releases
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
February 13, 2025
 · 
8 min read
Press Releases
AdvanCell Enters Into Strategic Collaboration with Lilly to Advance Novel Targeted Alpha Therapies for the Treatment of Cancer
February 10, 2025
 · 
1 min read
Press Releases
Most patients on Lilly’s Omvoh® (mirikizumab-mrkz) for Crohn’s disease achieved sustained clinical remission and endoscopic response at two years
February 7, 2025
 · 
12 min read
Press Releases
Lilly reports full Q4 2024 financial results and provides 2025 guidance
February 6, 2025
 · 
22 min read
Press Releases
Inotiv Reports First Quarter Financial Results for Fiscal 2025 and Provides Business Update
February 6, 2025
 · 
18 min read
Press Releases
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
January 30, 2025
 · 
10 min read
Press Releases
Roche receives FDA 510(k) clearance for the first blood test in the U.S. measuring Lp(a) in molar units
January 29, 2025
 · 
8 min read
Press Releases
Sonicu awarded Pharmacy Temperature Monitoring agreement with Premier, Inc.
January 28, 2025
 · 
3 min read
Load More